Expert consensus on antiviral therapy to treat hepatitis B/C virus-related hepatocellular carcinoma
Expert Panel of Antiviral Therapy for Hepatocellul;

..............page:321-326

Management of clinical diagnosis, evaluation, and antiviral therapy for HBV-related cirrhosis
Experts in combined team of the major special proj;

..............page:327-335

Galectin-3 expression in peripheral blood mononuclear cells of chronic hepatitis B patients treated with pegylated interferon alpha-2a
Li Yi;,Wu Xiaoling;,Yu Long;

..............page:336-339

Association between the PNPLA3 I148M polymorphism and chronic hepatitis B in a Qingdao Han Chinese population
jiang man ;, jiang xiang jun ;, li chang yan ;, lin zhong hua ;, wang wei bin ;, xin yong ning ;, xuan shi ying ;, zhang ding ding ;

..............page:340-343

Influence of liver function on pregnancy outcome of women with hepatitis B virus who receive individualized nutritional management
Dong Xiaojing;,Luo Xiaodong;,Xu Min;

..............page:344-348

A comparative study of high-or low-dose terlipressin therapy in patients with cirrhosis and type 1 hepatorenal syndrome
Peng Jianxin;,Wan Shiqian;,Wan Xuefa;,Zhu Qingjing;

..............page:349-353

Effect of siRNA-mediated silencing of Notch2 on proliferation of the HepG2 human hepatocellular carcinoma cells
Ding Shixiong;,Hu Airong;,Hu Yaoren;,Li Jianfang;,Liang Xiaoyue;,Ying Liping;

..............page:354-357

Serum glycoproteome profiling by lectin affinity microarray to distinguish the various stages of primary liver carcinogenesis
deng wei ;, hu heng ;, huang tian ren ;, jing rui ;, li ji lin ;, liu yin kun ;, sun chun ;, yu jia hua ;, zhang chun yan ;

..............page:358-363

Role of endoplasmic reticulum stress in D-GalN/LPS-induced acute liver failure
pu zheng fu ;, ren feng ;, wang xin xin ;, wen zuo ;, yang bing zhang ;, yin ji ming ;, zhang jing ;, zhang xiang ying ;, zheng su jun ;

..............page:364-368

Effect of intermittent hypoxia on lipid metabolism in liver cells and the underlying mechanism
Shen Wei;,Sun Zhongxin;

..............page:369-373

Association between APOC3 promoter region polymorphisms and non-alcoholic fatty liver disease
geng ning ;, jiang man ;, jiang xiang jun ;, lin zhong hua ;, liu zuo gang ;, niu tong hong ;, wang jian ;, xin yong ning ;, zhang mei ;

..............page:374-379

Clinical correlates of histopathology in non-obese non-alcoholic fatty liver disease
bian dong xue ;, jiang yan ming ;, liu hong ;, liu jing ;, lou guo qiang ;, lu zuo ;, qian jian cheng ;, shi jun ping ;, zuo yun hao ;

..............page:380-382

Fructose as a risk factor of nonalcoholic fatty liver disease
Chen Yi;,Li Youming;

..............page:383-385

Role of USP18 in interferon resistance and hepatitis B virus chronic infection
Yang Liu;,Zhou Junying;

..............page:386-388

Identification of hepatitis B virus quasispecies by ultra-deep sequencing
Gong Ling;,Wang Mingjie;,Zhang Xinxin;

..............page:389-392

What are the limits of efficacy for immunotherapy against hepatocellular carcinoma and its clinical availability
Ding Jia;,Wang Hong;,Wu Jian;

..............page:393-396

Recent advances in understanding the differentiation of mesenchymal stromal cells into hepatocytes and the related clinical research for improving management of end-stage liver disease
Gao Zhiliang;,He Hongliang;

..............page:397-400